Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocean Harvest Technology is a leading developer and supplier of seaweed-based animal feed additives designed to improve animal performance and health. The company utilizes its proprietary OceanFeed platform to create bioactive blends of macroalgae that serve as natural alternatives to synthetic ingredients and antibiotics in livestock production. Their products target a wide range of species, including swine, poultry, ruminants, and aquaculture, by optimizing gut health and immune response. Headquartered in the United Kingdom with production facilities in Vietnam, the company focuses on the global transition toward sustainable and antibiotic-free animal protein production. Ocean Harvest is publicly traded on the London Stock Exchange's AIM market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocean Harvest Technology.